TEV-50717
TV50717-CNS-30047
Phase 3 small_molecule terminated
Quick answer
TEV-50717 for Tourette Syndrome is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 3 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Tourette Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated